Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Utrogestan versus Cetrotide for prevention of premature LH surge during IVF
IRCT20110301005942N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of progesterone and cetrorelix in female infertility (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Number of embryos and Serum LH level. Started Feb 2018; status: completed.
02
Drugs
progesteronecetrorelix
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20110301005942N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110301005942N6.